Bioavailability of EPA + DHA in a SMEDS Formulation

Exclusion Criteria

• •Screening lab test of clinical significance
• •Positive urine drug screen
• •Clinically significant endocrine, cardiovascular, renal, hepatic, pulmonary, pancreatic, neurologic, gastrointestinal or biliary disorder
• •Uncontrolled hypertension
• •Recent history or presence of cancer
• •Difficulty swallowing capsules
• •Recent blood donation or blood loss
• •Recent consumption of high-dose fish oil or fish
• •Recent use of any prescribed medication or over-the-counter medicinal products, including herbal or dietary supplements (except daily omega-3 fatty acid-free vitamin and/or mineral supplement or occasional use of acetaminophen or non-steroidal anti-inflammatory drugs)
• •Signs or symptoms of active infection or has recently taken antibiotics
• •Recent history or strong potential for drug or alcohol abuse
• •Pregnant, planning to be pregnant during the study, lactating or of childbearing potential and unwilling to commit to use of a medically approved form of contraception throughout the study (note: hormonal contraceptive use is not allowed)